Christopher D. Roberts

Christopher D. Roberts

Director Ejecutivo en Civetta Therapeutics LLC .

54 años
Health Technology
Consumer Services

Perfil

Christopher D.
Roberts
is currently the Chief Executive Officer at Civetta Therapeutics LLC since 2021.
Prior to this, he was the Chief Scientific Officer at Black Diamond Therapeutics, Inc. from 2019 to 2021.
He also worked as the Vice President-Chemistry & Early Development at Syros Pharmaceuticals, Inc. from 2015 to 2017.
Before that, he was the VP & Head-Host Defense Discovery Performance Unit at GSK Plc from 2009 to 2015.
Dr. Roberts holds a doctorate degree from the University of California, Riverside and an undergraduate degree from Whitworth University.

Cargos activos de Christopher D. Roberts

EmpresasCargoInicio
Director Ejecutivo 02/09/2021
Todos los cargos activos de Christopher D. Roberts

Antiguos cargos conocidos de Christopher D. Roberts.

EmpresasCargoFin
BLACK DIAMOND THERAPEUTICS, INC. Director Técnico/Científico/I+D 11/08/2021
SYROS PHARMACEUTICALS, INC. Corporate Officer/Principal 01/03/2017
GSK PLC Corporate Officer/Principal 01/03/2015
Ver el detalle de la experiencia de Christopher D. Roberts.

Formación de Christopher D. Roberts.

Whitworth University Undergraduate Degree
University of California, Riverside Doctorate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Christopher D. Roberts.

Relaciones

23

Relaciones de 1er grado

6

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas3
BLACK DIAMOND THERAPEUTICS, INC.

Health Technology

SYROS PHARMACEUTICALS, INC.

Health Technology

GSK PLC

Health Technology

Empresas privadas1

Health Technology

Ver las conexiones de la empresa
  1. Bolsa de valores
  2. Insiders
  3. Christopher D. Roberts
-40% Oferta por Tiempo Limitado: Nuestras suscripciones le guían hacia las mejores inversiones del mañana.
APROVÉCHELO AHORA